mFluiDx is developing a point-of-care molecular test - the “SIMPLE CHIP” that achieves cost parity with rapid antigen tests while delivering PCR equivalent results with multiple pathogens tested at the same time
mFluiDx is developing a point-of-care molecular test - the “SIMPLE CHIP” that achieves cost parity with rapid antigen tests while delivering PCR equivalent results with multiple pathogens tested at the same time.
mFluiDx is developing a point-of-care molecular test - the “SIMPLE CHIP” that achieves cost parity with rapid antigen tests while delivering PCR equivalent results with multiple pathogens tested at the same time
mFluiDx is developing a point-of-care molecular test - the “SIMPLE CHIP” that achieves cost parity with rapid antigen tests while delivering PCR equivalent results with multiple pathogens tested at the same time.